GlassScriptPhysician profile
Jonathan D Klein
NPI 1356500623
$3,762.55
in general payments reported to CMS, 2019-2025
18 companies · $1,239 in 2025
The $1,239 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,806 · 2020: $35.51 · 2021: $12.09 · 2022: $258 · 2023: $207 · 2024: $206 · 2025: $1,239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,264 · Travel and Lodging: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,264.19 |
| Travel and Lodging | $387.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,558.18 | 2019-2025 | |
| Medtronic, INC. | $515.33 | 2022-2024 | Ligasure, Signia |
| Covidien LP | $176.13 | 2019 | |
| Baxter Healthcare | $85.25 | 2019 | |
| Integra Lifesciences Corporation | $60.15 | 2020-2022 | |
| Ethicon US, LLC | $54.20 | 2020-2025 | Surgiflo Hemostatic Matrix, Vistaseal, Surgicel Nu-Knit |
| Takeda Pharmaceuticals U.S.A., INC. | $52.80 | 2022-2025 | Gattex |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.46 | 2025 | Jardiance |
| Myriad Genetic Laboratories, INC. | $37.00 | 2021-2025 | Myrisk |
| Davol INC. | $30.23 | 2025 | Ventralight St |
| Novo Nordisk INC | $26.56 | 2024 | Ozempic, Rybelsus |
| Lifenet Health | $23.80 | 2023 | |
| Eisai INC. | $23.01 | 2019 | |
| Mallinckrodt Hospital Products INC. | $19.44 | 2025 | Terlivaz |
| Organogenesis INC. | $19.23 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $18.45 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.31 | 2023 | Andexxa |
| Olympus America INC. | $12.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.